SlideShare a Scribd company logo
1 of 36
By- Saud Aslam Ansari
M. Pharm (Pharmacology)
SPER, Jamia Hamdard
Anthelmintic
Presentation Outline:-
1) Introduction
2) Anthelmintics
3) Types of worms
4) GLOBAL SCENERIO
5) INDIAN SCENERIO
6) Classification of Drugs
7) Drug of Choice
8) References
2
Introduction
• Helminthiasis also known as worm infection is any macro
parasitic disease of humans and other animals in which a part
of the body is infected with parasitic worms known as
helminths.
• There are numerous species of these parasites which are
broadly classified into tapeworms, flukes ,and roundworms.
• They often live in the gastrointestinal tract of their hosts but
they may also burrow into other organs where they induce
physiological damage.
• Helminthiasis is prevalent globally about 1/3rd of world’s
population harbours them but is more common in developing
countries with poorer personal and environmental hygiene.
3
Anthelmintics
• Anthelmintics are drugs that either kill (vermicide) or expel
(vermifuge) infesting helminths.
• The choice of drug for each worm infestation is based not only
on efficacy but also on lack of side effects/toxicity ease of
administration (preferably single dose) and low cost.
• Development of resistance has not been a problem in the
clinical use of anthelmintics.
4
Pathogenesis
• Intestinal worms cause a variety of pathologic changes in the
mucosa, some reflecting physical and chemical damage to the
tissues, others resulting from immunopathologic responses.
Hookworms (Ancylostoma and Necator) actively suck blood
from mucosal capillaries.
• The anticoagulants secreted by the worms cause the wounds to
bleed for prolonged periods, resulting in considerable blood
loss. Heavy infections in malnourished hosts are associated
with anemia and protein loss.
• Diversion of host nutrients by competition from worms is
probably unimportant, but interference with normal digestion
and absorption may well aggravate undernutrition.
5
Cont.
• The tapeworm Diphyllobothrium latum can cause vitamin B12
deficiency through direct absorption of this factor.
• Many helminths undertake extensive migrations through body
tissues, which both damage tissues directly and initiate
hypersensitivity reactions. The skin, lungs, liver, and intestines
are the organs most affected.
• Feeding by worms upon host tissues is an important cause of
pathology, particularly when it induces hyperplastic and
metaplastic changes in epithelia.
For example, liver fluke infections lead to hyperplasia of the bile
duct epithelium.
6
Types of worms
Nemathelminthes (Roundworms)
• The migration of the larval forms and eggs transmission
through skin contact in moist soil and in tropical areas causes
migraine ,eosinophilia and pulmonary related problems.
• The common infections occurring with intestinal worms
include Ascaris lumbricoides, Trichuris trichiura, Necator
americanus and Ancylostoma duodenal with the household
aggregation of infection.
• The eggs are deposited on perianal area that is due to self
infection.
• These infections also occur due to the contaminated surfaces
like carpets, curtains etc.
7
Cont.
Trematoda (Flukes)
• Flukes are the parasitic trematodes of Schistosoma species
which are transmitted through direct contact with fresh water.
• They penetrate into the intact human skin and enter the
capillaries and then migrate to the central and portal system
where they mature.
• Acute schistosomiasis also known as Katayama fever, which is
a form of visceral larval migraines.
• The adult male and female pairs ultimately migrate to the
superior mesenteric veins and ureteric vesicles.
• The eggs are then shed in the faeces and urine.
8
Cont.
Cestoda (Tapeworms)
• Humans are the intermediate host for the Taenia solium with
the development of the tissue cysts.
• After the ingestion of the uncooked beef (T. saginata} or pork
it develops the cysts and it causes the mild abdominal
symptoms.
• The infestations of the central nervous systems caused due to
the pork tapeworm or flukes are known as neurocysticercosis
which is treated through albendazole and praziquantel.
9
GLOBAL SCENERIO:
• An estimated 120 million people in tropical and sub tropical
areas of the world are infected with lympathic filariasis of
these, 25 million men have genital disease (most commonly
hydrocoele) and almost 15 million; mostly women, have
lymphoedema or elephantiasis of the leg.
• A recent study suggests that during the past 13 years
>96.71million cases were prevented or cured with
MDA(Methylenedioxyamphetamine) treatment, yet, as many
as36 million cases of hydrocoele and lymphoedema remain.
• One of the leading causes of global disability LF(Lympathic
Filariasis) accounts for 2.8 million DALYs(Disability Adjacent
Life Year)
10
INDIAN SCENERIO
• A district-level endemicity map created in India in the year2000, shows that
of the 289 districts as many as 257 were found to be endemic.
• About 553 million people are exposed to risk of infection and of them
about 146 million live in urban and the remaining in rural areas.
• About 31 millions are estimated to be carriers and over 23million suffer
from filarial disease menifestations in India.
• B. Malayi is prevalent in the states of Kerela, Tamil Nadu, Andhra Pradesh,
Madhya pradesh, Orissa, Assam, West Bengal.
• Bihar has highest endemicity (over17%) followed by kerela (15.7%) and
UttarPradesh(14.6%).
• Andhra Pradesh and Tamil Nadu Has About 10%endemicity.
• Goa showed the lowest endemicity(>1%), followed by
Lakshwadeep(1.8%), Madhya Pradesh(above 3%)and Assam (5%).
11
TAPEWORM
INFECTION(CESTODIASIS):
GLOBAL SCENERIO:
• Greatest infection is found in the temperate zones including
several parts of Eurasia Australia, some parts of America and
Northeast Africa.
• Worldwide distribution of the zoonotic strains of Echinococcus
granulosus and geographical endemicity.
INDIAN SCENERIO:
• The disease is endemic in India.
• High prevalence is reported from Kashmir, Andhra Pradesh,
Tamil Nadu and Central India.
12
Classification of Drugs
13
1. Mebendazole
• It is a benzimidazole introduced in 1972.
• This congener of thiabendazole became very popular because
it retained the broad-spectrum anthelmintic activity but not the
toxicity of its predecessor.
• It has produced nearly 100% cure rate/reduction in egg count
in roundworm, hook worm (both species).
• The immobilizing and lethal action of Mebendazole on worms
is rather slow takes 2-3 days to develop.
14
Mechanism of action-
• The site of action of Mebendazole is
the microtubular protein ‘B-tubulin’
of the parasite.
• It binds to B-tubulin of susceptible
worms with high affinity and
inhibits its polymerization.
• Intracellular microtubules in the
cells of the worm are gradually lost
• In addition, it probably blocks
glucose uptake in the parasite and
depletes its glycogen stores.
15
Cont.
Pharmacokinetics-
• Absorption of Mebendazole from intestines is minimal 75-
90% of an oral dose is passed in the faeces.
• The fraction absorbed is excreted mainly as inactive
metabolites in urine/faeces.
Adverse effects-
• Diarrhoea, nausea & abdominal pain have attend edits use in
heavy infestation.
• Allergic reactions, loss of hair & granulocytopenia have been
reported with high doses.
16
2. Albendazole
• It is a subsequently introduced congener of Mebendazole.
• Retains the broad-spectrum activity and excellent tolerability
of its predecessor, and has the advantage of single dose
administration in many infestations.
• One dose treatment has produced cure rates in ascariasis,
hookworm (both species) & enterobiasis which are
comparable to 3 day treatment with Mebendazole.
MOA-
• The mechanism of action of Albendazole is similar to that of
Mebendazole.
17
Cont.
Pharmacokinetics-
• Absorption of Albendazole after oral administration is
significant, but inconsistent.
• It is enhanced when the drug is taken with fatty meal.
• The fraction absorbed is converted by first pass metabolism to
its sulfoxide metabolite which has potent anthelmintic action.
• Albendazole sulfoxide is widely distributed in the body, enters
brain and is excreted in urine & exert anthelmintic activity in
tissues as well.
Adverse effects-
• Gastrointestinal side effects, dizziness.
• Prolonged use has caused headache, fever, alopecia, jaundice. 18
3. Thiabendazole
• It was the first benzimidazole poly antihelmintic introduced in
1961, which covered practically all species of nematodes
infesting the g.i.t— roundworm, hookworm, pin worm.
MOA-
• It also inhibits development of the eggs of worms & kills
larvae.
Pharmacokinetics-
• Since thiabendazole is well absorbed from g.i.t systemic
adverse effects are common.
• Adverse effects-
• nausea, vomiting, abdominal pain, diarrhoea, giddiness,
impairment of alertness, itching, etc. 19
4. Pyrantel Pamoate
• It was introduced in 1969 for pin worm infestation in children
use soon extended to roundworm and hookworm as well.
• Efficacy against Ascaris, Enterobius and Ancylostoma is high
and comparable to that of mebendazole.
MOA-
• Pyrantel causes activation of nicotinic cholinergic receptors in
the worms resulting in persistent depolarization slowly
developing contracture and spastic paralysis.
• Worms are then expelled.
Pharmacokinetics-
• Only 10-15% of an oral dose of Pyrantel Pamoate is absorbed
this is partly metabolized and excreted in urine. 20
5. Piperazine
• Introduced in 1950, it is a highly active drug against Ascaris
and Enterobius achieves 90-100% cure rates.
• However, because of the availability at more convenient and
better tolerated Albendazole/mebendazole it is now considered
a second choice drug.
Mechanism of action-
• Piperazine causes hyperpolarization of Ascaris muscle by a
GABA agonistic action.
• Opening of Cl channels causes relaxation and depresses
responsiveness to contractile action of ACh.
• Flaccid paralysis occurs and worms are expelled alive.
21
Cont.
Pharmacokinetics-
• A considerable fraction of the oral dose of Piperazine is
absorbed.
• It is partly metabolized in liver and excreted in urine.
Adverse Effect-
• Piperazine is safe, but nausea, vomiting, abdominal discomfort
and urticaria may be felt.
• Dizziness and excitement occur at high doses toxic doses
produce convulsions death is due to respiratory failure.
22
6. Diethyl Carbamazine Citrate
• Developed in 1948, it is the first drug for filariasis caused by
the nematodes Wuchereria bancrofti (90% cases) &
Brugiamalayi.
MOA-
• Diethylcarbamazine is microfilaricidal.
• It has a highly selective effect on microfilariae (Mf).
• A dose of 2 mg/kg TDS clears Mf of W. bancrofti and B.
malayi from peripheral blood in 7 days.
• The most important action of DEC appears to be alteration of
organelle membranes of the Mf promoting cell death.
23
Cont.
Pharmacokinetics-
• DEC is absorbed after oral ingestion distributed all over the
body metabolized in liver and excreted in urine.
• Excretion is faster in acidic urine.
• Plasma t'z of usual clinical doses is 4—12 hours depending on
urinary pH.
Adverse Effects-
• Side effects are common but generally not serious.
• Nausea, loss of appetite, headache, weakness & dizziness are
the usual complaints
24
7. Ivermectin
• It is an extremely potent semisynthetic derivative of the
antinematodal principle obtained from Streptomyces
avermitilis.
• It is the drug of choice in onchocerciasis and strongyloidiasis.
• It is effective against microfilaria of W.bacrofti and B.malayi.
25
MECHANISM OF ACTION
Ivermectin
Activates glutamate-gated chloride channels increase Gaba
(gama-aminobutyric acid) transmission in worms
Hyperpolarisation and paralysis of worms
Deaths/phagocytises of worms
26
Cont.
Pharmacokinetics
• It is given orally rapidly absorbed widely distributed to various
tissues metabolized in the liver and excreted mainly in faeces
Side effects
• Itching, skin rashes, oedema, headache, fever, muscle and joint
pain.
Clinical uses
• Onchoerciasis -Treatment is with a single oral dose of
ivermectin,150 mg/kg, with water on an empty stomach.
• Strongyloidiasis - Two daily of 200 mg/kg.
27
8. Niclosamide
• Niclosamide is a highly effective drug against cestodes
infesting man—Taenia saginata, T. solium, Diphyllobothrium
latum andHymenolepis nana, as well as pin worm.
Mechanism of action
• Niclosamide act by inhibiting oxidative phosphorylation in
mitochondria and interfering with anaerobic generation of ATP
by the tapeworm.
28
Cont.
Adverse effects
• Niclosamide is tasteless and non irritating.
• It is minimally absorbed from g.i.t.—no systemic toxicity
occurs.
• It is well tolerated minor abdominal symptoms are produced
occasionally.
• Malaise (discomfort,illness), pruritus (severe itching of skin)
and light headedness are rare.
• Niclosamide is safe during pregnancy and in patients with
poor health
29
It is effective in the treatment of trematodes and cestodes but not for
Nematodes.
Mechanism of action
Praziquante
Influx of calcium ion into the tegument
Increased muscular contraction and spastic paralysis
At higher concentration
Damage tegument
Death of the parasite
9. Praziquantel
30
Cont.
Pharmacokinetics-
• It is readily absorbed after oral administration undergoes
extensive first-pass metabolism in liver, highly bound to
plasma protein, crosses the BBB and excreted mainly in urine.
Adverse effects-
• Dizziness, nausea, vomiting, abdominal discomfort,headache,
drowsiness, skin rashes, itching, muscle and joint pain.
31
Drug of Choice
worm First choice of drugs Alternative drugs
ROUND WORM
(NEMATODES)
Ascaris lumbricoides
MEBENDAZOLE,
ALBENDAZOLE,
PYRANTEL
PIPERAZINE,
LEVANISOLE,
IVERMECTIN
HOOK WORM
Accylostoma duodnale
Necator americanus
Pyrantel, Mebendazole
Albendazole,
Mebendazole, Albendazole
Levamisole
Pyrantel
PIN WORM
Enterobius
vermicularis
Pyrantel,
Albendazole,
Mebendazole
piperazine
Thread worm
Strongyloides stercoralis
Ivermectin Albendazole
Whip worm
Trichuris trichura
Trichinella spiralis
Albendazole,
Mebendazole
Albendazole,
Mebendazole
33
Guineaworm
Dracunculas medinesis Metronidazole Mebendazole
Tapeworm
(cestodes)
Taenia saginata
Taenia solium
Hymenolepis nana
Neurocysticercosis
Praziquantel
Praziquantel
Praziquantel
Albendazole
Niclosamide
Niclosamide
Niclosamide
Praziquental
Hydatid disease
Echinococcus granulosus
E.multilocularis
Albendazole
Albendazole
Mebendazole
Cont.
34
References
• Goodman and Gilman's The Pharmacological Basis of Therapeutics, by
Bjorn Knollmann (Author), Laurence Brunton (Author) ,14th Edition,
Section VII: Chemotherapy of Infectious Diseases, Chapter 68:
Chemotherapy of Helminth Infections.
• Essentials of Medical Pharmacology by K. D. Tripath, Edition-Eighth,
Publisher- Jaypee Brothers Medical Publishers.
• Rang & Dale's Pharmacology, 9th Edition, Authors: James M. Ritter, Rod J.
Flower, Graeme Henderson, Yoon Kong Loke, David MacEwan,
Humphrey Rang.
• https://www.ncbi.nlm.nih.gov/books/NBK8191/#:~:text=Pathogenesis%3A
%20direct%20damage%20caused%20by,suck%20blood%20from%20muc
osal%20capillaries.
35
Thank You

More Related Content

What's hot

Anti helminthic drugs
Anti helminthic drugsAnti helminthic drugs
Anti helminthic drugsBinaya Subedi
 
Aminoglycoside by sumit
Aminoglycoside by sumitAminoglycoside by sumit
Aminoglycoside by sumitSumit Kumar
 
Macrolides and lincosamide
Macrolides and lincosamideMacrolides and lincosamide
Macrolides and lincosamideZulcaif Ahmad
 
Aminoglycosides
AminoglycosidesAminoglycosides
AminoglycosidesDrSahilKumar
 
fluoroquinolones medchem- oriental college of pharmacy
fluoroquinolones medchem- oriental college of pharmacyfluoroquinolones medchem- oriental college of pharmacy
fluoroquinolones medchem- oriental college of pharmacyKaushik Kuche
 
Antiulcer
AntiulcerAntiulcer
AntiulcerMrunalAkre
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugsRahul Bhati
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugsSuvarta Maru
 
antiviral drugs medicinal chemistry by padala varaprasad
antiviral drugs medicinal chemistry by padala varaprasadantiviral drugs medicinal chemistry by padala varaprasad
antiviral drugs medicinal chemistry by padala varaprasadVaraprasad Padala
 
Quinolones.pptx
Quinolones.pptxQuinolones.pptx
Quinolones.pptxAyushi Dogne
 
Urinary tract anti infective agents
Urinary tract anti infective agentsUrinary tract anti infective agents
Urinary tract anti infective agentsAkash Saxena
 
Medicinal Chemistry of Hetrocyclic Compound
Medicinal Chemistry of Hetrocyclic CompoundMedicinal Chemistry of Hetrocyclic Compound
Medicinal Chemistry of Hetrocyclic CompoundPuja Ramu Basule
 
Anti fungal Agents- Pharmacy-Medicinal Chemistry
Anti fungal Agents- Pharmacy-Medicinal ChemistryAnti fungal Agents- Pharmacy-Medicinal Chemistry
Anti fungal Agents- Pharmacy-Medicinal ChemistryAkhil Nagar
 
Aminoglycosides Dr Mukundam.pptx
Aminoglycosides  Dr Mukundam.pptxAminoglycosides  Dr Mukundam.pptx
Aminoglycosides Dr Mukundam.pptxDr. Mukundam Borah
 
Antiprotozoal Drugs- Medicinal Chemistry-Pharmacy
Antiprotozoal Drugs- Medicinal Chemistry-PharmacyAntiprotozoal Drugs- Medicinal Chemistry-Pharmacy
Antiprotozoal Drugs- Medicinal Chemistry-PharmacyAkhil Nagar
 

What's hot (20)

Anti helminthic drugs
Anti helminthic drugsAnti helminthic drugs
Anti helminthic drugs
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
 
Aminoglycoside by sumit
Aminoglycoside by sumitAminoglycoside by sumit
Aminoglycoside by sumit
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugs
 
Macrolides and lincosamide
Macrolides and lincosamideMacrolides and lincosamide
Macrolides and lincosamide
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
 
fluoroquinolones medchem- oriental college of pharmacy
fluoroquinolones medchem- oriental college of pharmacyfluoroquinolones medchem- oriental college of pharmacy
fluoroquinolones medchem- oriental college of pharmacy
 
Antiulcer
AntiulcerAntiulcer
Antiulcer
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
 
Antiprotozoal agents.pptx
Antiprotozoal agents.pptxAntiprotozoal agents.pptx
Antiprotozoal agents.pptx
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugs
 
antiviral drugs medicinal chemistry by padala varaprasad
antiviral drugs medicinal chemistry by padala varaprasadantiviral drugs medicinal chemistry by padala varaprasad
antiviral drugs medicinal chemistry by padala varaprasad
 
Aminoglycosides
AminoglycosidesAminoglycosides
Aminoglycosides
 
Quinolones.pptx
Quinolones.pptxQuinolones.pptx
Quinolones.pptx
 
Urinary tract anti infective agents
Urinary tract anti infective agentsUrinary tract anti infective agents
Urinary tract anti infective agents
 
Isoniazid
IsoniazidIsoniazid
Isoniazid
 
Medicinal Chemistry of Hetrocyclic Compound
Medicinal Chemistry of Hetrocyclic CompoundMedicinal Chemistry of Hetrocyclic Compound
Medicinal Chemistry of Hetrocyclic Compound
 
Anti fungal Agents- Pharmacy-Medicinal Chemistry
Anti fungal Agents- Pharmacy-Medicinal ChemistryAnti fungal Agents- Pharmacy-Medicinal Chemistry
Anti fungal Agents- Pharmacy-Medicinal Chemistry
 
Aminoglycosides Dr Mukundam.pptx
Aminoglycosides  Dr Mukundam.pptxAminoglycosides  Dr Mukundam.pptx
Aminoglycosides Dr Mukundam.pptx
 
Antiprotozoal Drugs- Medicinal Chemistry-Pharmacy
Antiprotozoal Drugs- Medicinal Chemistry-PharmacyAntiprotozoal Drugs- Medicinal Chemistry-Pharmacy
Antiprotozoal Drugs- Medicinal Chemistry-Pharmacy
 

Similar to antihelminthic.ppt

Anthelmintic and antiamoebic drugs ppt
Anthelmintic and antiamoebic drugs pptAnthelmintic and antiamoebic drugs ppt
Anthelmintic and antiamoebic drugs pptNarasimhamurthyM5
 
Protozoa and Helminth Parasites ppt by Dr.Prince.C.P
Protozoa and Helminth Parasites ppt by Dr.Prince.C.PProtozoa and Helminth Parasites ppt by Dr.Prince.C.P
Protozoa and Helminth Parasites ppt by Dr.Prince.C.PPRINCE C P
 
Neglected tropical dideases
Neglected tropical dideasesNeglected tropical dideases
Neglected tropical dideasesMamso
 
Travel alert --occupational health
Travel alert --occupational healthTravel alert --occupational health
Travel alert --occupational healthladdha1962
 
Antihelminth Drugs.ppt
Antihelminth Drugs.pptAntihelminth Drugs.ppt
Antihelminth Drugs.pptFredrickKemboy1
 
Parasitic infection
Parasitic infectionParasitic infection
Parasitic infectionDrSyed Asif
 
lec-7- parasitology. abdul salam najim mohammed
lec-7- parasitology. abdul salam najim mohammedlec-7- parasitology. abdul salam najim mohammed
lec-7- parasitology. abdul salam najim mohammedsalamkrbooly
 
Epidemiology and control of filariasis (Lymphatic Filariasis) in India
Epidemiology and control of filariasis (Lymphatic Filariasis) in IndiaEpidemiology and control of filariasis (Lymphatic Filariasis) in India
Epidemiology and control of filariasis (Lymphatic Filariasis) in IndiaReshma Ann Mathew
 
Introduction to anthelmintic drugs
Introduction to anthelmintic drugsIntroduction to anthelmintic drugs
Introduction to anthelmintic drugsSubramani Parasuraman
 
World malaria Day ppt.pptx
World malaria Day ppt.pptxWorld malaria Day ppt.pptx
World malaria Day ppt.pptxanjalatchi
 
Anthelmintics
AnthelminticsAnthelmintics
AnthelminticsShilpa Harak
 
Filariasis and Fascioliasis
Filariasis and FascioliasisFilariasis and Fascioliasis
Filariasis and Fascioliasishome education
 
Neglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptxNeglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptxAdhyaDubey1
 
Neglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptxNeglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptxAdhyaDubey1
 
Anthelmintic drugs
Anthelmintic drugsAnthelmintic drugs
Anthelmintic drugsManoharReddy183
 

Similar to antihelminthic.ppt (20)

Anthelmintic and antiamoebic drugs ppt
Anthelmintic and antiamoebic drugs pptAnthelmintic and antiamoebic drugs ppt
Anthelmintic and antiamoebic drugs ppt
 
Anthelmintic drugs
Anthelmintic drugsAnthelmintic drugs
Anthelmintic drugs
 
Presentation
PresentationPresentation
Presentation
 
Protozoa and Helminth Parasites ppt by Dr.Prince.C.P
Protozoa and Helminth Parasites ppt by Dr.Prince.C.PProtozoa and Helminth Parasites ppt by Dr.Prince.C.P
Protozoa and Helminth Parasites ppt by Dr.Prince.C.P
 
Neglected tropical dideases
Neglected tropical dideasesNeglected tropical dideases
Neglected tropical dideases
 
Travel alert --occupational health
Travel alert --occupational healthTravel alert --occupational health
Travel alert --occupational health
 
Antihelminth Drugs.ppt
Antihelminth Drugs.pptAntihelminth Drugs.ppt
Antihelminth Drugs.ppt
 
Anthelmintic [Pharmacology]
Anthelmintic [Pharmacology]Anthelmintic [Pharmacology]
Anthelmintic [Pharmacology]
 
Parasitic infection
Parasitic infectionParasitic infection
Parasitic infection
 
lec-7- parasitology. abdul salam najim mohammed
lec-7- parasitology. abdul salam najim mohammedlec-7- parasitology. abdul salam najim mohammed
lec-7- parasitology. abdul salam najim mohammed
 
Epidemiology and control of filariasis (Lymphatic Filariasis) in India
Epidemiology and control of filariasis (Lymphatic Filariasis) in IndiaEpidemiology and control of filariasis (Lymphatic Filariasis) in India
Epidemiology and control of filariasis (Lymphatic Filariasis) in India
 
Introduction to anthelmintic drugs
Introduction to anthelmintic drugsIntroduction to anthelmintic drugs
Introduction to anthelmintic drugs
 
World malaria Day ppt.pptx
World malaria Day ppt.pptxWorld malaria Day ppt.pptx
World malaria Day ppt.pptx
 
Anthelmintics
AnthelminticsAnthelmintics
Anthelmintics
 
Anthelmintic.[Pharmacology]
Anthelmintic.[Pharmacology]Anthelmintic.[Pharmacology]
Anthelmintic.[Pharmacology]
 
HS-_Filariasis.pdf
HS-_Filariasis.pdfHS-_Filariasis.pdf
HS-_Filariasis.pdf
 
Filariasis and Fascioliasis
Filariasis and FascioliasisFilariasis and Fascioliasis
Filariasis and Fascioliasis
 
Neglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptxNeglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptx
 
Neglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptxNeglected-tropical-diseasesindia and world.pptx
Neglected-tropical-diseasesindia and world.pptx
 
Anthelmintic drugs
Anthelmintic drugsAnthelmintic drugs
Anthelmintic drugs
 

More from ashharnomani

Protein microarray .pptx
Protein microarray .pptxProtein microarray .pptx
Protein microarray .pptxashharnomani
 
Nucleic acid microarray.pptx
Nucleic acid microarray.pptxNucleic acid microarray.pptx
Nucleic acid microarray.pptxashharnomani
 
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptxMETHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptxashharnomani
 
Computational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptxComputational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptxashharnomani
 
INFLAMMATION.pptx
INFLAMMATION.pptxINFLAMMATION.pptx
INFLAMMATION.pptxashharnomani
 
hit identification.pptx
hit identification.pptxhit identification.pptx
hit identification.pptxashharnomani
 
Oral contraceptives.pptx
Oral contraceptives.pptxOral contraceptives.pptx
Oral contraceptives.pptxashharnomani
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxashharnomani
 
Methods in Rational Drug design.pptx
Methods in Rational Drug design.pptxMethods in Rational Drug design.pptx
Methods in Rational Drug design.pptxashharnomani
 
pharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxpharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxashharnomani
 
Terminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptxTerminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptxashharnomani
 
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxTEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxashharnomani
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxashharnomani
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptxashharnomani
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxashharnomani
 
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptxSPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptxashharnomani
 
progesterone receptor.pptx
progesterone receptor.pptxprogesterone receptor.pptx
progesterone receptor.pptxashharnomani
 
GH RECEPTORS.pptx
GH RECEPTORS.pptxGH RECEPTORS.pptx
GH RECEPTORS.pptxashharnomani
 
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptxestablishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptxashharnomani
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxashharnomani
 

More from ashharnomani (20)

Protein microarray .pptx
Protein microarray .pptxProtein microarray .pptx
Protein microarray .pptx
 
Nucleic acid microarray.pptx
Nucleic acid microarray.pptxNucleic acid microarray.pptx
Nucleic acid microarray.pptx
 
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptxMETHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
METHODS FOLLOWED IN TRADITIONAL DRUG DESIGN-1.pptx
 
Computational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptxComputational Prediction Of Protein-1.pptx
Computational Prediction Of Protein-1.pptx
 
INFLAMMATION.pptx
INFLAMMATION.pptxINFLAMMATION.pptx
INFLAMMATION.pptx
 
hit identification.pptx
hit identification.pptxhit identification.pptx
hit identification.pptx
 
Oral contraceptives.pptx
Oral contraceptives.pptxOral contraceptives.pptx
Oral contraceptives.pptx
 
Toxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptxToxicokinetic evaluation in preclinical studies.pptx
Toxicokinetic evaluation in preclinical studies.pptx
 
Methods in Rational Drug design.pptx
Methods in Rational Drug design.pptxMethods in Rational Drug design.pptx
Methods in Rational Drug design.pptx
 
pharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptxpharmacophoremapping05-180503150916-converted.pptx
pharmacophoremapping05-180503150916-converted.pptx
 
Terminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptxTerminologies In OECD Guidelines.pptx
Terminologies In OECD Guidelines.pptx
 
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxTEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
 
WHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptxWHO international drug monitoring programme.pptx
WHO international drug monitoring programme.pptx
 
Teratogenicity.pptx
Teratogenicity.pptxTeratogenicity.pptx
Teratogenicity.pptx
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptx
 
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptxSPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
SPONTANEOUS REPORTING SYSTEM & GUIDELINES FOR ADR REPORTING.pptx
 
progesterone receptor.pptx
progesterone receptor.pptxprogesterone receptor.pptx
progesterone receptor.pptx
 
GH RECEPTORS.pptx
GH RECEPTORS.pptxGH RECEPTORS.pptx
GH RECEPTORS.pptx
 
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptxestablishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
establishing_pv_centers_in_industry_AND_NATIONAL_PROGRAMME[1].pptx
 
ANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptxANTISENSE OLIGONUCLEOTIDES.pptx
ANTISENSE OLIGONUCLEOTIDES.pptx
 

Recently uploaded

ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptxENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptxAnaBeatriceAblay2
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 

Recently uploaded (20)

ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptxENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 

antihelminthic.ppt

  • 1. By- Saud Aslam Ansari M. Pharm (Pharmacology) SPER, Jamia Hamdard Anthelmintic
  • 2. Presentation Outline:- 1) Introduction 2) Anthelmintics 3) Types of worms 4) GLOBAL SCENERIO 5) INDIAN SCENERIO 6) Classification of Drugs 7) Drug of Choice 8) References 2
  • 3. Introduction • Helminthiasis also known as worm infection is any macro parasitic disease of humans and other animals in which a part of the body is infected with parasitic worms known as helminths. • There are numerous species of these parasites which are broadly classified into tapeworms, flukes ,and roundworms. • They often live in the gastrointestinal tract of their hosts but they may also burrow into other organs where they induce physiological damage. • Helminthiasis is prevalent globally about 1/3rd of world’s population harbours them but is more common in developing countries with poorer personal and environmental hygiene. 3
  • 4. Anthelmintics • Anthelmintics are drugs that either kill (vermicide) or expel (vermifuge) infesting helminths. • The choice of drug for each worm infestation is based not only on efficacy but also on lack of side effects/toxicity ease of administration (preferably single dose) and low cost. • Development of resistance has not been a problem in the clinical use of anthelmintics. 4
  • 5. Pathogenesis • Intestinal worms cause a variety of pathologic changes in the mucosa, some reflecting physical and chemical damage to the tissues, others resulting from immunopathologic responses. Hookworms (Ancylostoma and Necator) actively suck blood from mucosal capillaries. • The anticoagulants secreted by the worms cause the wounds to bleed for prolonged periods, resulting in considerable blood loss. Heavy infections in malnourished hosts are associated with anemia and protein loss. • Diversion of host nutrients by competition from worms is probably unimportant, but interference with normal digestion and absorption may well aggravate undernutrition. 5
  • 6. Cont. • The tapeworm Diphyllobothrium latum can cause vitamin B12 deficiency through direct absorption of this factor. • Many helminths undertake extensive migrations through body tissues, which both damage tissues directly and initiate hypersensitivity reactions. The skin, lungs, liver, and intestines are the organs most affected. • Feeding by worms upon host tissues is an important cause of pathology, particularly when it induces hyperplastic and metaplastic changes in epithelia. For example, liver fluke infections lead to hyperplasia of the bile duct epithelium. 6
  • 7. Types of worms Nemathelminthes (Roundworms) • The migration of the larval forms and eggs transmission through skin contact in moist soil and in tropical areas causes migraine ,eosinophilia and pulmonary related problems. • The common infections occurring with intestinal worms include Ascaris lumbricoides, Trichuris trichiura, Necator americanus and Ancylostoma duodenal with the household aggregation of infection. • The eggs are deposited on perianal area that is due to self infection. • These infections also occur due to the contaminated surfaces like carpets, curtains etc. 7
  • 8. Cont. Trematoda (Flukes) • Flukes are the parasitic trematodes of Schistosoma species which are transmitted through direct contact with fresh water. • They penetrate into the intact human skin and enter the capillaries and then migrate to the central and portal system where they mature. • Acute schistosomiasis also known as Katayama fever, which is a form of visceral larval migraines. • The adult male and female pairs ultimately migrate to the superior mesenteric veins and ureteric vesicles. • The eggs are then shed in the faeces and urine. 8
  • 9. Cont. Cestoda (Tapeworms) • Humans are the intermediate host for the Taenia solium with the development of the tissue cysts. • After the ingestion of the uncooked beef (T. saginata} or pork it develops the cysts and it causes the mild abdominal symptoms. • The infestations of the central nervous systems caused due to the pork tapeworm or flukes are known as neurocysticercosis which is treated through albendazole and praziquantel. 9
  • 10. GLOBAL SCENERIO: • An estimated 120 million people in tropical and sub tropical areas of the world are infected with lympathic filariasis of these, 25 million men have genital disease (most commonly hydrocoele) and almost 15 million; mostly women, have lymphoedema or elephantiasis of the leg. • A recent study suggests that during the past 13 years >96.71million cases were prevented or cured with MDA(Methylenedioxyamphetamine) treatment, yet, as many as36 million cases of hydrocoele and lymphoedema remain. • One of the leading causes of global disability LF(Lympathic Filariasis) accounts for 2.8 million DALYs(Disability Adjacent Life Year) 10
  • 11. INDIAN SCENERIO • A district-level endemicity map created in India in the year2000, shows that of the 289 districts as many as 257 were found to be endemic. • About 553 million people are exposed to risk of infection and of them about 146 million live in urban and the remaining in rural areas. • About 31 millions are estimated to be carriers and over 23million suffer from filarial disease menifestations in India. • B. Malayi is prevalent in the states of Kerela, Tamil Nadu, Andhra Pradesh, Madhya pradesh, Orissa, Assam, West Bengal. • Bihar has highest endemicity (over17%) followed by kerela (15.7%) and UttarPradesh(14.6%). • Andhra Pradesh and Tamil Nadu Has About 10%endemicity. • Goa showed the lowest endemicity(>1%), followed by Lakshwadeep(1.8%), Madhya Pradesh(above 3%)and Assam (5%). 11
  • 12. TAPEWORM INFECTION(CESTODIASIS): GLOBAL SCENERIO: • Greatest infection is found in the temperate zones including several parts of Eurasia Australia, some parts of America and Northeast Africa. • Worldwide distribution of the zoonotic strains of Echinococcus granulosus and geographical endemicity. INDIAN SCENERIO: • The disease is endemic in India. • High prevalence is reported from Kashmir, Andhra Pradesh, Tamil Nadu and Central India. 12
  • 14. 1. Mebendazole • It is a benzimidazole introduced in 1972. • This congener of thiabendazole became very popular because it retained the broad-spectrum anthelmintic activity but not the toxicity of its predecessor. • It has produced nearly 100% cure rate/reduction in egg count in roundworm, hook worm (both species). • The immobilizing and lethal action of Mebendazole on worms is rather slow takes 2-3 days to develop. 14
  • 15. Mechanism of action- • The site of action of Mebendazole is the microtubular protein ‘B-tubulin’ of the parasite. • It binds to B-tubulin of susceptible worms with high affinity and inhibits its polymerization. • Intracellular microtubules in the cells of the worm are gradually lost • In addition, it probably blocks glucose uptake in the parasite and depletes its glycogen stores. 15
  • 16. Cont. Pharmacokinetics- • Absorption of Mebendazole from intestines is minimal 75- 90% of an oral dose is passed in the faeces. • The fraction absorbed is excreted mainly as inactive metabolites in urine/faeces. Adverse effects- • Diarrhoea, nausea & abdominal pain have attend edits use in heavy infestation. • Allergic reactions, loss of hair & granulocytopenia have been reported with high doses. 16
  • 17. 2. Albendazole • It is a subsequently introduced congener of Mebendazole. • Retains the broad-spectrum activity and excellent tolerability of its predecessor, and has the advantage of single dose administration in many infestations. • One dose treatment has produced cure rates in ascariasis, hookworm (both species) & enterobiasis which are comparable to 3 day treatment with Mebendazole. MOA- • The mechanism of action of Albendazole is similar to that of Mebendazole. 17
  • 18. Cont. Pharmacokinetics- • Absorption of Albendazole after oral administration is significant, but inconsistent. • It is enhanced when the drug is taken with fatty meal. • The fraction absorbed is converted by first pass metabolism to its sulfoxide metabolite which has potent anthelmintic action. • Albendazole sulfoxide is widely distributed in the body, enters brain and is excreted in urine & exert anthelmintic activity in tissues as well. Adverse effects- • Gastrointestinal side effects, dizziness. • Prolonged use has caused headache, fever, alopecia, jaundice. 18
  • 19. 3. Thiabendazole • It was the first benzimidazole poly antihelmintic introduced in 1961, which covered practically all species of nematodes infesting the g.i.t— roundworm, hookworm, pin worm. MOA- • It also inhibits development of the eggs of worms & kills larvae. Pharmacokinetics- • Since thiabendazole is well absorbed from g.i.t systemic adverse effects are common. • Adverse effects- • nausea, vomiting, abdominal pain, diarrhoea, giddiness, impairment of alertness, itching, etc. 19
  • 20. 4. Pyrantel Pamoate • It was introduced in 1969 for pin worm infestation in children use soon extended to roundworm and hookworm as well. • Efficacy against Ascaris, Enterobius and Ancylostoma is high and comparable to that of mebendazole. MOA- • Pyrantel causes activation of nicotinic cholinergic receptors in the worms resulting in persistent depolarization slowly developing contracture and spastic paralysis. • Worms are then expelled. Pharmacokinetics- • Only 10-15% of an oral dose of Pyrantel Pamoate is absorbed this is partly metabolized and excreted in urine. 20
  • 21. 5. Piperazine • Introduced in 1950, it is a highly active drug against Ascaris and Enterobius achieves 90-100% cure rates. • However, because of the availability at more convenient and better tolerated Albendazole/mebendazole it is now considered a second choice drug. Mechanism of action- • Piperazine causes hyperpolarization of Ascaris muscle by a GABA agonistic action. • Opening of Cl channels causes relaxation and depresses responsiveness to contractile action of ACh. • Flaccid paralysis occurs and worms are expelled alive. 21
  • 22. Cont. Pharmacokinetics- • A considerable fraction of the oral dose of Piperazine is absorbed. • It is partly metabolized in liver and excreted in urine. Adverse Effect- • Piperazine is safe, but nausea, vomiting, abdominal discomfort and urticaria may be felt. • Dizziness and excitement occur at high doses toxic doses produce convulsions death is due to respiratory failure. 22
  • 23. 6. Diethyl Carbamazine Citrate • Developed in 1948, it is the first drug for filariasis caused by the nematodes Wuchereria bancrofti (90% cases) & Brugiamalayi. MOA- • Diethylcarbamazine is microfilaricidal. • It has a highly selective effect on microfilariae (Mf). • A dose of 2 mg/kg TDS clears Mf of W. bancrofti and B. malayi from peripheral blood in 7 days. • The most important action of DEC appears to be alteration of organelle membranes of the Mf promoting cell death. 23
  • 24. Cont. Pharmacokinetics- • DEC is absorbed after oral ingestion distributed all over the body metabolized in liver and excreted in urine. • Excretion is faster in acidic urine. • Plasma t'z of usual clinical doses is 4—12 hours depending on urinary pH. Adverse Effects- • Side effects are common but generally not serious. • Nausea, loss of appetite, headache, weakness & dizziness are the usual complaints 24
  • 25. 7. Ivermectin • It is an extremely potent semisynthetic derivative of the antinematodal principle obtained from Streptomyces avermitilis. • It is the drug of choice in onchocerciasis and strongyloidiasis. • It is effective against microfilaria of W.bacrofti and B.malayi. 25
  • 26. MECHANISM OF ACTION Ivermectin Activates glutamate-gated chloride channels increase Gaba (gama-aminobutyric acid) transmission in worms Hyperpolarisation and paralysis of worms Deaths/phagocytises of worms 26
  • 27. Cont. Pharmacokinetics • It is given orally rapidly absorbed widely distributed to various tissues metabolized in the liver and excreted mainly in faeces Side effects • Itching, skin rashes, oedema, headache, fever, muscle and joint pain. Clinical uses • Onchoerciasis -Treatment is with a single oral dose of ivermectin,150 mg/kg, with water on an empty stomach. • Strongyloidiasis - Two daily of 200 mg/kg. 27
  • 28. 8. Niclosamide • Niclosamide is a highly effective drug against cestodes infesting man—Taenia saginata, T. solium, Diphyllobothrium latum andHymenolepis nana, as well as pin worm. Mechanism of action • Niclosamide act by inhibiting oxidative phosphorylation in mitochondria and interfering with anaerobic generation of ATP by the tapeworm. 28
  • 29. Cont. Adverse effects • Niclosamide is tasteless and non irritating. • It is minimally absorbed from g.i.t.—no systemic toxicity occurs. • It is well tolerated minor abdominal symptoms are produced occasionally. • Malaise (discomfort,illness), pruritus (severe itching of skin) and light headedness are rare. • Niclosamide is safe during pregnancy and in patients with poor health 29
  • 30. It is effective in the treatment of trematodes and cestodes but not for Nematodes. Mechanism of action Praziquante Influx of calcium ion into the tegument Increased muscular contraction and spastic paralysis At higher concentration Damage tegument Death of the parasite 9. Praziquantel 30
  • 31. Cont. Pharmacokinetics- • It is readily absorbed after oral administration undergoes extensive first-pass metabolism in liver, highly bound to plasma protein, crosses the BBB and excreted mainly in urine. Adverse effects- • Dizziness, nausea, vomiting, abdominal discomfort,headache, drowsiness, skin rashes, itching, muscle and joint pain. 31
  • 33. worm First choice of drugs Alternative drugs ROUND WORM (NEMATODES) Ascaris lumbricoides MEBENDAZOLE, ALBENDAZOLE, PYRANTEL PIPERAZINE, LEVANISOLE, IVERMECTIN HOOK WORM Accylostoma duodnale Necator americanus Pyrantel, Mebendazole Albendazole, Mebendazole, Albendazole Levamisole Pyrantel PIN WORM Enterobius vermicularis Pyrantel, Albendazole, Mebendazole piperazine Thread worm Strongyloides stercoralis Ivermectin Albendazole Whip worm Trichuris trichura Trichinella spiralis Albendazole, Mebendazole Albendazole, Mebendazole 33
  • 34. Guineaworm Dracunculas medinesis Metronidazole Mebendazole Tapeworm (cestodes) Taenia saginata Taenia solium Hymenolepis nana Neurocysticercosis Praziquantel Praziquantel Praziquantel Albendazole Niclosamide Niclosamide Niclosamide Praziquental Hydatid disease Echinococcus granulosus E.multilocularis Albendazole Albendazole Mebendazole Cont. 34
  • 35. References • Goodman and Gilman's The Pharmacological Basis of Therapeutics, by Bjorn Knollmann (Author), Laurence Brunton (Author) ,14th Edition, Section VII: Chemotherapy of Infectious Diseases, Chapter 68: Chemotherapy of Helminth Infections. • Essentials of Medical Pharmacology by K. D. Tripath, Edition-Eighth, Publisher- Jaypee Brothers Medical Publishers. • Rang & Dale's Pharmacology, 9th Edition, Authors: James M. Ritter, Rod J. Flower, Graeme Henderson, Yoon Kong Loke, David MacEwan, Humphrey Rang. • https://www.ncbi.nlm.nih.gov/books/NBK8191/#:~:text=Pathogenesis%3A %20direct%20damage%20caused%20by,suck%20blood%20from%20muc osal%20capillaries. 35